Healthcare Services

Knee Bursitis Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

April 2, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Knee Bursitis Market Across 2026–2030?

The knee bursitis market size has shown significant expansion in recent years. This market is set to increase from $2.86 billion in 2025 to $3.06 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to its historical growth, including a rise in the occurrence of knee injuries and repetitive stress conditions, increased involvement in sports and physical activities, the well-established application of imaging in diagnosing musculoskeletal issues, an expanding aging population experiencing joint disorders, and the accessibility of anti-inflammatory medications.

The market for knee bursitis is projected to experience robust expansion over the coming years. This market is anticipated to reach $3.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the projection period include an escalating demand for less invasive therapies, a heightened emphasis on prompt diagnosis and preventative measures, increased utilization of physiotherapy services, the development of orthopedic care facilities, and enhanced availability of diagnostic imaging in developing regions. Key trends expected during the forecast period encompass a growing inclination towards non-surgical management of knee bursitis, a rise in the application of imaging for precise diagnosis, wider acceptance of physical therapy and rehabilitation, an increase in outpatient and conservative treatment methods, and better patient understanding of early knee injury care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Which Market Drivers Are Supporting The Expansion Of The Knee Bursitis Market?

The expanding occurrence of bone-related ailments is anticipated to boost the expansion of the knee bursitis market in the future. These conditions, which include osteoporosis, arthritis, and bone cancer, impact the skeletal system’s structure, strength, and overall function. The growing incidence of bone-related diseases stems from factors such as older populations, inactive lifestyles, inadequate nutrition, and shifts in the environment. Specifically, conditions like osteoarthritis and rheumatoid arthritis can trigger knee bursitis by inducing inflammation and undue stress on the knee bursa, leading to discomfort, swelling, and diminished joint mobility. An example demonstrating this trend is data from October 2024 by Healthy Bones Australia, an Australia-based national nonprofit organization dedicated to osteoporosis prevention and bone health awareness, which estimated that 6.2 million Australians aged 50 and over, representing approximately 67% of this demographic, suffered from poor bone health. This figure is predicted to climb significantly to around 7.7 million people living with osteopenia or osteoporosis by 2033. Consequently, the rising prevalence of bone-related conditions is fueling the growth of the knee bursitis market. The expanding number of individuals with diabetes is projected to drive the future growth of the knee bursitis market. Diabetes is a long-term ailment characterized by the body’s inability to adequately manage blood sugar levels, either from inadequate insulin generation or inefficient insulin utilization. The escalation in diabetes diagnoses can be linked to factors like inactive routines, poor eating habits, and inherited genetic tendencies. Those with diabetes are susceptible to developing knee bursitis due to inflammation resulting from sustained pressure on the knees, compromised immune system function, or other diabetes-related complications. For example, in June 2024, a report from the National Health Service (NHS), a UK-based public health organization, indicated that the count of individuals registered with pre-diabetes rose to 3,615,330 in 2023, an 18% increase from 3,065,825 in 2022. Thus, the growing diabetic population is a key factor propelling the expansion of the knee bursitis market.

What Segmentation Levels Are Considered In The Knee Bursitis Market?

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Clinical Evaluation, Imaging Techniques, Laboratory And Procedural Tests, Differential Diagnosis Support

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Clinical Evaluation: Medical History Assessment, Physical Examination

2) By Imaging Techniques: X-Ray, Ultrasound, Magnetic Resonance Imaging

3) By Laboratory And Procedural Tests: Bursa Fluid Aspiration, Blood Tests

4) By Differential Diagnosis Support: Infection Exclusion Tests, Inflammatory Marker Assessment, Trauma-Related Assessment

Which Leading Firms Are Contributing To The Growth Of The Knee Bursitis Market?

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company, AbbVie Inc., Johnson & Johnson, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Stryker Corporation, Zimmer Biomet Holdings Inc., Arthrex Inc., Smith & Nephew plc, Medtronic plc, Exactech Inc., Conformis Inc., Bioventus LLC, Horizon Therapeutics plc, Amneal Pharmaceuticals Inc.

Read the full knee bursitis market report here:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

How Is The Knee Bursitis Market Distributed Across Key Geographic Regions?

North America was the largest region in the knee bursitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Knee Bursitis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16460&type=smp

Browse Through More Reports Similar to the Global Knee Bursitis Market 2026, By The Business Research Company

Gouty Arthritis Global Market Report

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Osteoarthritis Global Market Report

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Knee Implants Global Market Report

https://www.thebusinessresearchcompany.com/report/knee-implants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795